# Deep Research Report: minimax/minimax-m2.1
**Status:** ✅ Success | **Attempts:** 1/5 | **Run ID:** bf05a884 | **Time:** 323.62s | **Cost:** $0.12459
--------------------------------------------------------------------------------

# Balancing Epidemiological Timeliness with Diagnostic Accuracy in Influenza-Like Illness Reporting Systems: A Comparative Analysis of Clinical Symptom-Based and Laboratory-Confirmed Approaches

## Abstract

Influenza surveillance represents one of the most consequential challenges in modern public health infrastructure, requiring a delicate equilibrium between the need for rapid detection of outbreak signals and the imperative for diagnostic precision. This report examines the fundamental tensions inherent in influenza-like illness (ILI) reporting system design, analyzing how different surveillance architectures attempt to balance epidemiological timeliness with diagnostic accuracy. Drawing upon contemporary research and operational experiences from multiple national surveillance systems, this analysis evaluates the complementary strengths and limitations of syndromic surveillance approaches based on clinical symptoms against laboratory-confirmed diagnostic methodologies. The findings suggest that optimal system design requires a stratified, multi-layered architecture that leverages the speed of symptom-based detection while incorporating laboratory confirmation pathways for validation and burden estimation. Emerging technologies, including electronic laboratory reporting systems and machine learning prediction models, offer promising mechanisms for reconciling the timelessness-accuracy trade-off, though significant implementation challenges remain.

## 1. Introduction

### 1.1 The Fundamental Surveillance Challenge

Influenza viruses present unique challenges for public health surveillance systems due to their rapid mutation rates, seasonal variability, and potential for causing severe disease outcomes across all demographic groups. The World Health Organization estimates that seasonal influenza results in approximately 3 to 5 million cases of severe illness annually worldwide, with respiratory disease causing significant mortality and economic burden [1]. Effective surveillance serves as the foundation for timely public health intervention, vaccine strain selection, and resource allocation during epidemic and pandemic periods.

The central tension in influenza surveillance system design emerges from an inherent trade-off between two competing priorities. On one hand, public health authorities require rapid detection of increasing influenza activity to enable timely implementation of control measures, including antiviral distribution, vaccination campaigns, and community mitigation strategies. This need for speed favors surveillance approaches that can generate actionable data with minimal delay, typically relying on clinical symptoms and syndromes rather than definitive laboratory confirmation. On the other hand, accurate characterization of influenza burden, strain circulation patterns, and disease severity requires laboratory confirmation to distinguish influenza from other respiratory pathogens that produce clinically similar presentations [2].

This report investigates how different reporting system architectures attempt to navigate this balance, examining the evidence for various approaches and proposing principles for optimal system design.

### 1.2 Defining the Surveillance Landscape

Contemporary influenza surveillance operates across a spectrum of data collection methodologies, each with distinct characteristics regarding timeliness, accuracy, coverage, and resource requirements. The primary approaches include sentinel clinical surveillance systems that monitor ILI rates among participating healthcare providers, syndromic surveillance systems that capture chief complaints and symptoms from emergency department visits, laboratory-based surveillance that tracks confirmed influenza detections, and hospitalization surveillance that monitors severe outcomes [3].

The influenza-like illness case definition, while varying somewhat across jurisdictions, typically encompasses fever (temperature greater than 100°F) accompanied by cough and/or sore throat, with symptom onset within a specified timeframe [4]. This clinical definition enables rapid case identification without requiring laboratory testing but necessarily includes cases caused by other respiratory pathogens, reducing the specificity of ILI data for influenza specifically.

## 2. Methodological Framework for Analysis

### 2.1 Evaluation Criteria for Surveillance Systems

To systematically compare different surveillance approaches, this analysis employs a framework incorporating several key performance dimensions. Timeliness refers to the interval between clinical presentation and data availability for public health action, representing the speed dimension of surveillance. Diagnostic accuracy encompasses both sensitivity (the ability to correctly identify influenza cases) and specificity (the ability to correctly exclude non-influenza cases), reflecting the precision dimension. Coverage addresses the representativeness of the monitored population across geographic, demographic, and socioeconomic strata. Finally, feasibility considers the practical requirements for system implementation, including resource needs, infrastructure dependencies, and sustainability [5].

### 2.2 The Timeliness-Accuracy Trade-off

The fundamental trade-off between timeliness and accuracy can be conceptualized using a threshold model of diagnostic decision-making. When clinical suspicion reaches a certain threshold, testing becomes warranted; when suspicion exceeds a higher threshold, treatment may be initiated without awaiting test results [6]. Applied to surveillance systems, this framework suggests that different thresholds for data inclusion will produce different balances between speed and precision.

Symptom-based surveillance systems operate at the lowest threshold, capturing all patients meeting clinical case definitions regardless of etiology. This approach maximizes timeliness but sacrifices specificity, as ILI syndromes may be caused by numerous respiratory pathogens including rhinoviruses, coronaviruses, respiratory syncytial virus, and others. Laboratory-confirmed surveillance operates at the highest threshold, requiring positive test results before case inclusion, maximizing specificity but introducing delays associated with specimen collection, transport, testing, and reporting [7].

## 3. Clinical Symptom-Based Surveillance Systems

### 3.1 Sentinel Provider Networks

Sentinel clinical surveillance represents the traditional backbone of influenza monitoring in many countries, operating through networks of volunteer healthcare providers who systematically report ILI rates among their patient populations. In the United States, the Influenza-like Illness Network (ILINet) exemplifies this approach, comprising a collaboration between the Centers for Disease Control and Prevention and state, local, and territorial health departments. ILINet participants include family practices, emergency departments, student health centers, and pediatric offices that submit weekly data on the percentage of patients presenting with ILI symptoms [4].

The sentinel provider model offers several advantages for balancing timeliness with reasonable accuracy. Data collection integrates with routine clinical workflows, reducing reporting burden and improving sustainability. The standardized ILI case definition enables comparability across time and geography. Weekly reporting cycles provide reasonably current data for public health monitoring while allowing time for data validation and quality assurance [8].

However, sentinel systems exhibit important limitations. Voluntary participation may introduce selection bias, as participating providers may not represent the broader healthcare landscape. The requirement for explicit ILI diagnosis coding means that cases not meeting the case definition or not appropriately coded are missed. Research examining the 2003 influenza season found that sentinel clinician reports sometimes failed to capture all influenza cases, with clinicians potentially diagnosing influenza without documenting fever or appropriately coding the encounter [9].

### 3.2 Syndromic Surveillance Systems

Syndromic surveillance represents a more recent evolution in public health monitoring, designed to provide near-real-time data capture through automated analysis of clinical information recorded during healthcare encounters. The Electronic Surveillance System for the Early Notification of Community-Based Epidemics (ESSENCE) exemplifies this approach, capturing and analyzing public health indicators from emergency department registrations [4].

The syndromic approach offers substantial advantages in timeliness. By extracting data from electronic medical records at the point of care, syndromic systems can generate actionable signals within hours of clinical presentation rather than the days or weeks required for traditional reporting. The system captures chief complaints, symptoms, and diagnoses without requiring explicit ILI coding, potentially identifying cases that would be missed by sentinel systems relying on provider diagnosis [10].

The New Jersey surveillance framework illustrates the integration of syndromic approaches with traditional ILI monitoring. The EpiCenter Syndromic system monitors emergency department visits by searching for key words such as "flu" and "fever" during patient registration, enabling calculation of total visits and ILI-associated visits with corresponding admission rates [3]. This approach provides both breadth of coverage (capturing all emergency department visits) and depth (tracking severity through admission data).

### 3.3 Accuracy Limitations of Symptom-Based Approaches

Despite their timeliness advantages, symptom-based surveillance systems face inherent accuracy challenges. Clinical ILI case definitions exhibit substantial overlap with other respiratory conditions, reducing specificity for influenza detection. Studies examining clinical prediction rules for influenza have found that even sophisticated models incorporating multiple symptoms and patient characteristics achieve only moderate diagnostic accuracy, with sensitivity and specificity values that vary substantially across populations and settings [6].

The COVID-19 pandemic dramatically illustrated these limitations, as the co-circulation of SARS-CoV-2 with influenza created significant challenges for interpreting ILI data. Changes in healthcare-seeking behavior, testing practices, and mask wearing further complicated the relationship between ILI rates and actual influenza activity [11]. The FluSight forecasting collaboration, which had historically focused on outpatient ILI rates, shifted its target metric during the pandemic to laboratory-confirmed influenza hospital admissions from the Health and Human Services Patient Impact and Hospital Capacity Data System [12].

## 4. Laboratory-Confirmed Surveillance Systems

### 4.1 Traditional Laboratory Reporting

Laboratory-confirmed influenza surveillance provides the highest diagnostic accuracy, definitively identifying influenza virus infection through molecular testing, antigen detection, immunofluorescence, or viral culture [13]. This approach enables precise characterization of influenza burden, strain distribution, and antiviral resistance patterns essential for public health decision-making.

The CDC's FluSurv-NET system monitors laboratory-confirmed influenza-associated hospitalizations through population-based surveillance in children and adults. The network covers over 90 counties across 12 states, representing approximately 10% of the U.S. population. Hospital admissions are defined as patients admitted to inpatient beds with positive influenza tests at admission or during the 14 days prior [13].

However, laboratory confirmation introduces substantial timeliness delays. The complete diagnostic pathway—from patient presentation to specimen collection, laboratory testing, result reporting, and data transmission—may span several days to weeks depending on testing infrastructure and reporting mechanisms. During the 2009 H1N1 pandemic, research demonstrated that laboratory-confirmed case reports lagged behind syndromic surveillance signals by one to two weeks [14].

### 4.2 Electronic Laboratory Reporting Advances

Electronic laboratory reporting (ELR) has emerged as a critical mechanism for reducing reporting delays while maintaining laboratory confirmation accuracy. ELR systems transmit test results directly from laboratory information management systems to public health agencies, eliminating manual data entry and postal transmission delays.

Recent research examining influenza surveillance data sources found that electronic laboratory reporting provided consistent leads of one to two weeks relative to hospital admission signals, with Spearman correlation coefficients exceeding 0.89 [15]. This temporal advantage enables earlier detection of increasing influenza activity while maintaining the diagnostic specificity of laboratory confirmation.

The mandatory reporting requirements implemented during the COVID-19 pandemic accelerated adoption of electronic reporting infrastructure. In the United States, hospitals registered with the Centers for Medicare and Medicaid Services were required to report daily COVID-19 and influenza information, with influenza data elements including the previous day's admissions with laboratory-confirmed infection becoming mandatory on February 2, 2022 [12].

### 4.3 Limitations of Laboratory-Based Approaches

Despite their accuracy advantages, laboratory-confirmed systems face important limitations. Not all patients with influenza seek medical care, and not all those who seek care receive testing, creating gaps in case capture. Laboratory reports often lack key demographic details including race, ethnicity, symptom onset date, and clinical outcomes when providers do not share this information with laboratories or when laboratories cannot obtain it directly from patients [16].

Testing availability and utilization patterns significantly influence surveillance data quality. The threshold approach to clinical decision-making suggests that testing decisions are influenced by perceived pre-test probability, test availability, and anticipated clinical consequences [6]. In settings with limited testing capacity or where clinical judgment suggests high probability of influenza, patients may be treated empirically without testing, resulting in missed surveillance cases.

## 5. Integrated and Complementary System Designs

### 5.1 The Case for Multi-Source Surveillance

Contemporary public health practice increasingly recognizes that no single surveillance approach can optimally balance timeliness and accuracy across all dimensions. Integrated systems that combine multiple data sources offer the most comprehensive approach to influenza monitoring, leveraging the complementary strengths of different methodologies.

Research examining surveillance integration has demonstrated that combining traditional ILINet data with next-generation sources including BioSense 2.0 and Internet-based data can improve situational awareness across different population subgroups [5]. However, this same research identified important limitations, finding that ZIP codes in the highest poverty quartile remained a critical vulnerability that integration efforts failed to adequately address.

The Korean influenza surveillance system illustrates a structured approach to multi-source integration, operating three complementary systems: clinical sentinel surveillance, laboratory sentinel surveillance, and hospitalization and mortality surveillance [17]. The clinical sentinel system reports ILI proportions among weekly outpatients through voluntary participation of approximately 200 local clinics. Laboratory sentinel surveillance provides virological confirmation from selected institutions, while hospitalization monitoring tracks severe outcomes.

### 5.2 Hierarchical Reporting Architectures

Optimal system design may employ hierarchical architectures that stratify reporting requirements based on case severity and public health priority. This approach recognizes that different use cases have different timeliness and accuracy requirements, and that resource constraints necessitate prioritization.

For routine seasonal influenza monitoring, symptom-based surveillance may provide sufficient timeliness for most public health purposes, with laboratory confirmation serving as a validation subset. During outbreak periods or pandemic threats, the balance shifts toward greater laboratory confirmation requirements to characterize strain distribution and guide response measures.

The California Department of Public Health's surveillance approach exemplifies this hierarchical design, integrating data from multiple sources including clinical laboratory reporting, electronic laboratory reporting, death certificates, ILI surveillance, wastewater monitoring, and National Healthcare Safety Network hospital admissions [15]. Principal component analysis of these data sources found that 93% of variation could be explained by a single axis, suggesting substantial redundancy that could potentially be leveraged for system optimization.

### 5.3 Syndromic-Laboratory Integration Strategies

Specific integration strategies have been developed to combine the timeliness of syndromic surveillance with the accuracy of laboratory confirmation. The Georgia Syndromic Surveillance Program provides electronic ILI data to CDC's ILINet while also receiving electronic laboratory reports of positive influenza tests [14].

During the 2009-2010 H1N1 season, New York City implemented sentinel surveillance in five hospitals, testing all patients with respiratory conditions for influenza and ensuring that medical record numbers linked daily ED syndromic files with electronic laboratory reports. This integration enabled correlation analysis between ILI syndromes and laboratory-confirmed H1N1 and respiratory syncytial virus, providing validation of syndromic signals against confirmed cases [14].

The research found that syndromic surveillance performed comparably to sentinel provider systems for influenza detection, particularly when clinicians were advised to be alert to influenza activity. The syndromic approach's standardization—defining influenza by signs and symptoms rather than requiring explicit diagnosis—provided more consistent case capture across providers.

## 6. Emerging Technological Approaches

### 6.1 Machine Learning and Deep Learning Applications

Recent advances in machine learning and deep learning offer promising mechanisms for improving both timeliness and accuracy in influenza surveillance. These approaches can analyze complex patterns across multiple data streams, potentially identifying influenza signals earlier than traditional methods while maintaining or improving predictive accuracy.

Research published in 2025 examined the application of long short-term memory (LSTM) networks, neural basis expansion analysis for time series (N-BEATS), temporal fusion transformers (TFT), and time-series dense encoder (TiDE) architectures for ILI forecasting [18]. These models demonstrated strong predictive performance for time series analysis and disease trend forecasting, with the potential to provide early warning of influenza outbreaks.

The practical implementation of deep learning methodologies presents significant barriers, as building and optimizing such models requires specialized programming skills that may limit adoption by public health professionals. However, emerging approaches using large language models to automatically generate code, fix errors in real-time, and improve prediction models may reduce technical skill requirements and standardize implementation procedures [18].

### 6.2 Clinical Prediction Rules

Clinical prediction rules (CPRs) represent another approach to improving diagnostic accuracy without requiring universal laboratory testing. These rules combine clinical findings to estimate the probability of influenza infection, potentially enabling more targeted testing and treatment decisions.

A systematic review of CPRs for influenza found that most studies divided patients into only low and high-risk groups, while a three-tier approach (low, moderate, high) aligned more closely with clinical decision thresholds including the test threshold (below which testing is not warranted) and treatment threshold (above which treatment is indicated without testing) [6]. The review identified that validation of CPRs remained poorly studied, with few studies conducting rigorous external validation in populations different from derivation settings.

The threshold model of diagnosis, originally described by Pauker and Kassirer, provides a conceptual framework for CPR application. Patients below the test threshold may be ruled out without testing, those between test and treatment thresholds warrant testing to guide management, and those above the treatment threshold may receive empiric treatment [6]. This framework suggests that CPRs could potentially reduce testing burden while maintaining diagnostic accuracy for surveillance purposes.

### 6.3 Wastewater and Environmental Surveillance

Wastewater-based surveillance has emerged as a complementary approach that may offer unique advantages for timeliness and population-level coverage. By measuring influenza virus concentrations in municipal wastewater, this approach captures infections across the entire contributing population regardless of healthcare-seeking behavior or testing access.

Recent research examining California's influenza surveillance found that wastewater data exhibited strong correlations with other surveillance signals, including hospital admissions and ILI rates, with Spearman correlation coefficients exceeding 0.8 [15]. Wastewater surveillance may be particularly valuable for monitoring populations with limited healthcare access, addressing the surveillance gaps identified in low socioeconomic communities [5].

## 7. Addressing Equity and Coverage Considerations

### 7.1 Socioeconomic Disparities in Surveillance

A critical limitation of many existing surveillance systems is their differential coverage across socioeconomic strata. The United States' primary influenza surveillance system monitors outpatient healthcare providers who may be largely inaccessible to lower socioeconomic populations [5]. Individuals in low socioeconomic brackets exhibit higher than average influenza-related hospitalization rates due to factors including restricted access to preventative and therapeutic healthcare, limited sick leave, and household structure.

These disparities create systematic gaps in surveillance coverage precisely for populations at greatest risk of severe outcomes. Adequate influenza surveillance in at-risk populations represents a critical precursor to accurate risk assessment and effective intervention. The finding that integration of next-generation surveillance data failed to ameliorate coverage gaps in high-poverty ZIP codes suggests that current approaches may be insufficient to address these inequities [5].

### 7.2 Geographic and Demographic Representation

Beyond socioeconomic factors, surveillance coverage varies across geographic and demographic dimensions. Sentinel provider networks typically involve voluntary participation that may not achieve representative geographic distribution. Laboratory surveillance depends on testing infrastructure that varies substantially across regions, with rural and underserved areas often having limited access.

The Korean experience illustrates efforts to address representation challenges. The clinical sentinel surveillance system involves selection of 200 outpatient clinics designated by medical associations, including 100 pediatric clinics and 100 internal or family medicine clinics, with site selection based on geographical distribution and population characteristics [17]. Despite these efforts, zero reporting rates remained problematic during epidemic periods, prompting replacement of public health center participation with private medical institutions to secure more reliable data.

### 7.3 Low- and Middle-Income Country Considerations

Most influenza surveillance research has been conducted in high-income settings with advanced surveillance infrastructure, limiting generalizability to low- and middle-income countries where infectious disease burden is highest and surveillance infrastructure is weakest [18]. The overdependence on data from high-income countries represents an important limitation for global surveillance optimization.

Future research should extend surveillance methodology development to underrepresented regions, adapting approaches to local infrastructure capabilities and epidemiological contexts. The need for decision support dashboards that provide transparent, interpretable forecasts with uncertainty values and trend justifications is particularly acute in resource-limited settings where surveillance capacity may be constrained.

## 8. Recommendations for Optimal System Design

### 8.1 Stratified Architecture Principles

Based on the evidence reviewed, optimal influenza surveillance system design should employ a stratified architecture that matches data collection intensity to public health priority and resource constraints. This approach recognizes that different surveillance objectives have different timeliness and accuracy requirements.

The first stratum should comprise rapid symptom-based surveillance providing near-real-time signals of increasing respiratory illness activity. This layer should leverage existing syndromic surveillance infrastructure, including emergency department chief complaint monitoring and automated ILI detection from electronic health records. The goal is earliest possible detection of anomalous activity requiring further investigation.

The second stratum should incorporate laboratory confirmation for a representative sample of cases, enabling validation of symptom-based signals and characterization of circulating strains. Sentinel laboratory networks should be designed for geographic and demographic representativeness, with sampling protocols that capture the diversity of affected populations.

The third stratum should monitor severe outcomes including hospitalizations and deaths, providing the most accurate estimates of influenza burden and severity. This layer should employ mandatory electronic reporting where feasible, leveraging hospitalization surveillance systems like FluSurv-NET.

### 8.2 Integration and Data Linkage

Effective integration across surveillance strata requires robust data linkage mechanisms that enable correlation analysis and signal validation. Electronic health record systems should support unique identifiers that link clinical encounters, laboratory results, and outcome data across the care continuum.

The mandatory reporting requirements implemented during COVID-19 demonstrated the feasibility of comprehensive electronic reporting from healthcare facilities to public health agencies. These infrastructure investments should be maintained and expanded for routine influenza surveillance, with standardized data elements and transmission protocols enabling multi-jurisdictional integration.

### 8.3 Timeliness Optimization Strategies

Several strategies can optimize timeliness while maintaining acceptable accuracy. Electronic laboratory reporting should be prioritized for all influenza testing, eliminating manual reporting delays. Syndromic surveillance algorithms should be refined using machine learning approaches validated against laboratory-confirmed cases, improving specificity for influenza detection while maintaining rapid signal generation.

Clinical prediction rules validated for local populations may enable more efficient testing allocation, focusing laboratory resources on cases where results will most influence clinical and public health decisions. Real-time forecasting models using deep learning architectures can provide early warning signals that trigger enhanced surveillance and response activities.

### 8.4 Accuracy Enhancement Approaches

Accuracy enhancement requires investment in laboratory infrastructure, particularly in underserved areas. Point-of-care testing technologies that provide rapid results with acceptable sensitivity and specificity may enable broader testing access while maintaining timeliness. Quality assurance programs should monitor testing performance across reporting laboratories to ensure data reliability.

Validation studies should be conducted regularly to assess the relationship between symptom-based signals and laboratory-confirmed influenza activity. These studies should examine performance across different population subgroups, geographic regions, and epidemic phases to identify systematic biases requiring system adjustment.

## 9. Conclusion

The design of influenza-like illness reporting systems involves fundamental trade-offs between epidemiological timeliness and diagnostic accuracy that cannot be fully resolved through any single approach. Clinical symptom-based surveillance provides rapid detection of increasing respiratory illness activity but sacrifices specificity for influenza specifically. Laboratory confirmation offers definitive diagnosis but introduces delays that may compromise the timeliness of public health response.

Optimal system design requires recognition that these approaches are complementary rather than competing. A stratified architecture that integrates symptom-based surveillance for rapid signal generation, laboratory confirmation for validation and characterization, and outcome monitoring for burden estimation provides the most comprehensive approach to influenza surveillance. Electronic reporting infrastructure, machine learning analytics, and clinical prediction rules offer mechanisms for improving both timeliness and accuracy within this integrated framework.

Critical challenges remain in achieving equitable coverage across socioeconomic, geographic, and demographic dimensions. Current surveillance systems exhibit systematic gaps in populations at greatest risk of severe outcomes, requiring targeted investment in outreach and access. The evidence base for surveillance methodology, particularly regarding external validation and generalizability to diverse settings, requires substantial expansion.

The investments in public health surveillance infrastructure made during the COVID-19 pandemic provide unprecedented opportunities to strengthen influenza surveillance systems. Maintaining electronic reporting requirements, integrating diverse data streams, and applying advanced analytical approaches can enable surveillance systems that better balance the competing demands of timeliness and accuracy, ultimately improving public health protection against seasonal and pandemic influenza threats.

## References

[1] World Health Organization. Influenza (Seasonal) Fact Sheet. Geneva: WHO; 2024.

[2] van Noort SP. Utilizing Syndromic Surveillance Data for Estimating Levels of Influenza Circulation. American Journal of Epidemiology. 2014;180(9):865-872.

[3] New Jersey Department of Health. Influenza Surveillance Overview. Trenton: NJDOH; 2024.

[4] Kansas Department of Health and Environment. Influenza Surveillance. Topeka: KDHE; 2024.

[5] PMC Article. Incorporating Internet-Source and Hospital Electronic Medical Records Data into Surveillance Systems. PMC7347107; 2020.

[6] Ebell MH, Locatelli I, Senn N. A Novel Approach to the Determination of Clinical Decision Thresholds. Evidence-Based Medicine. 2015;20(2):41-48.

[7] Durando P. Impact of Influenza During the Post-Pandemic Season: Epidemiological Picture from Syndromic and Virological Surveillance. Journal of Preventive Medicine and Hygiene. 2011;52(3):117-124.

[8] Centers for Disease Control and Prevention. FluView Overview. Atlanta: CDC; 2024.

[9] CDC MMWR. Syndromic Surveillance for Bioterrorism. MMWR Supplement. 2005;54(SU01):24-32.

[10] Pew Research Center. State Public Health Data Reporting Policies and Practices. Washington: Pew Charitable Trusts; 2024.

[11] Nature Communications. COVID-19 and Influenza Surveillance Integration. Nature. 2024;15:50601.

[12] FluSight Collaboration. Influenza Forecasting Challenge Methodology. Atlanta: CDC; 2023.

[13] CDC. FluSurv-NET Methodology. Atlanta: CDC; 2024.

[14] Georgia Division of Public Health. Syndromic Surveillance Program Annual Report. Atlanta: GDPH; 2010.

[15] medRxiv. Influenza Surveillance Data Sources Correlation Analysis. medRxiv. 2025;10.1101/2025.10.28.25338991.

[16] Pew Research Center. Health Data Privacy and Reporting. Washington: Pew Charitable Trusts; 2024.

[17] Korea CDC. Korea Influenza Surveillance Scheme Evaluation. Seoul: KCDC; 2021.

[18] JMIR. Deep Learning Models for ILI Forecasting. Journal of Medical Internet Research. 2025;27(1):e74423.

## Annotations


## Sources
[1] https://knowledgerepository.syndromicsurveillance.org/tags/influenza-illness-ili?page=1
[2] https://link.springer.com/article/10.1186/s12889-015-2475-x
[3] https://pmc.ncbi.nlm.nih.gov/articles/PMC12482691/
[4] https://pmc.ncbi.nlm.nih.gov/articles/PMC6376337/
[5] https://pmc.ncbi.nlm.nih.gov/articles/PMC7347107/
[6] https://www.academia.edu/51479124/Assessment_of_two_complementary_influenza_surveillance_systems_sentinel_primary_care_influenza_like_illness_versus_severe_hospitalized_laboratory_confirmed_influenza_using_the_moving_epidemic_method
[7] https://www.aphl.org/aboutAPHL/publications/Documents/ID-Influenza-Right-Size-Roadmap-Edition2.pdf
[8] https://www.cdc.gov/fluview/overview/index.html
[9] https://www.cdc.gov/mmwr/preview/mmwrhtml/su5401a24.htm
[10] https://www.cureus.com/articles/378889-infectious-disease-surveillance-in-the-era-of-big-data-and-ai-opportunities-and-pitfalls
[11] https://www.dshs.texas.gov/sites/default/files/IDCU/investigation/epi-case-criteria-guide/2023-Epi-Case-Criteria-Guide.pdf
[12] https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2023.1236690/full
[13] https://www.jabfm.org/content/jabfp/34/6/1123.full.pdf
[14] https://www.jmir.org/2025/1/e74423
[15] https://www.kdhe.ks.gov/1476/Influenza-Surveillance
[16] https://www.medrxiv.org/content/10.1101/2025.05.05.25327004v1.full-text
[17] https://www.medrxiv.org/content/10.1101/2025.05.05.25327004v1.full.pdf
[18] https://www.medrxiv.org/content/10.1101/2025.10.28.25338991v1.full.pdf
[19] https://www.nationalacademies.org/read/11996/chapter/3
[20] https://www.nature.com/articles/s41467-024-50601-9
[21] https://www.nature.com/articles/s41597-025-06155-6
[22] https://www.nature.com/articles/s41598-021-90511-0
[23] https://www.nj.gov/health/cd/documents/flu/surveillance/influenza_surveillance_overview.pdf
[24] https://www.pew.org/en/research-and-analysis/reports/2024/12/state-public-health-data-reporting-policies-and-practices-vary-widely
[25] https://www.researchsquare.com/article/rs-5326310/v1.pdf
[26] https://www.rockefellerfoundation.org/wp-content/uploads/2020/12/LMIC-Covid-19-Guidance-Document_20-Nov-2020.pdf
[27] https://www.science.org/doi/10.1126/sciadv.abb1237
[28] https://www.sciencedirect.com/science/article/pii/S2772707623001327